Home

Centessa Pharmaceuticals plc - American Depositary Shares (CNTA)

15.75
-0.54 (-3.31%)

Centessa Pharmaceuticals is a clinical-stage biotechnology company focused on the discovery and development of innovative medicines to address unmet medical needs

The company's unique asset-centric approach leverages a diverse portfolio of drug candidates, targeting various diseases and conditions, particularly in areas such as oncology, immunology, and rare diseases. Centessa collaborates with leading scientific experts and employs advanced technologies to advance its therapeutic programs through clinical trials, aiming to bring transformative treatments to patients worldwide.

SummaryNewsPress ReleasesChartHistoricalFAQ
AeroVironment Posts Downbeat Results, Joins Box, CrowdStrike And Other Big Stocks Moving Lower In Wednesday's Pre-Market Sessionbenzinga.com
Via Benzinga · March 5, 2025
Why Twilio Shares Are Trading Higher By Over 18%; Here Are 20 Stocks Moving Premarketbenzinga.com
Via Benzinga · January 24, 2025
Cassava Sciences, Biohaven And Other Big Stocks Moving Lower In Monday's Pre-Market Sessionbenzinga.com
Via Benzinga · November 25, 2024
Maximus Reports Weak Earnings, Joins Atkore, PDD Holdings And Other Big Stocks Moving Lower In Thursday's Pre-Market Sessionbenzinga.com
Via Benzinga · November 21, 2024
Where Centessa Pharmaceuticals Stands With Analystsbenzinga.com
Via Benzinga · August 15, 2023
Centessa Pharmaceuticals: Q1 Earnings Insightsbenzinga.com
Via Benzinga · May 12, 2023
Sleep-Disorder Focused Centessa Pharmaceuticals Unveils Interim Data From Lead Program In Acutely Sleep-Deprived Healthy Volunteersbenzinga.com
Centessa Pharmaceuticals revealed promising interim Phase 1 trial results for ORX750, demonstrating significant improvements in sleep latency for acutely sleep-deprived healthy volunteers. The company plans to advance ORX750 into Phase 2 studies targeting narcolepsy and idiopathic hypersomnia in Q4 2024.
Via Benzinga · September 10, 2024
Calavo Growers Posts Better-Than-Expected Earnings, Joins Tesla, Oracle, Mission Produce And Other Big Stocks Moving Higher On Tuesdaybenzinga.com
Via Benzinga · September 10, 2024
Centessa Rockets To Three-Year High On $5 Billion Narcolepsy Opportunityinvestors.com
The company tested a potential narcolepsy treatment in healthy, but sleep-deprived, volunteers.
Via Investor's Business Daily · September 10, 2024
CNTA Stock Earnings: Centessa Pharmaceuticals Misses EPS for Q2 2024investorplace.com
CNTA stock results show that Centessa Pharmaceuticals missed analyst estimates for earnings per share the second quarter of 2024.
Via InvestorPlace · August 13, 2024
CNTA Stock Earnings: Centessa Pharmaceuticals Beats EPS for Q1 2024investorplace.com
CNTA stock results show that Centessa Pharmaceuticals beat analyst estimates for earnings per share the first quarter of 2024.
Via InvestorPlace · May 13, 2024
CNTA Stock Earnings: Centessa Pharmaceuticals Beats EPS for Q4 2023investorplace.com
CNTA stock results show that Centessa Pharmaceuticals beat analyst estimates for earnings per share the fourth quarter of 2023.
Via InvestorPlace · March 28, 2024
7 Biotech Stocks Ready to Ride the Sector’s Resurgenceinvestorplace.com
With investors seeking new opportunities with certain segments appearing stretched, biotech stocks offer a viable canvas.
Via InvestorPlace · March 18, 2024
Why Take-Two Interactive Software Shares Are Trading Lower By Around 9%? Here Are Other Stocks Moving In Friday's Mid-Day Sessionbenzinga.com
Shares of Take-Two Interactive Software, Inc. (NASDAQ: TTWO) fell sharply during Friday’s session following third-quarter results.
Via Benzinga · February 9, 2024
SPS Commerce Posts Upbeat Results, Joins Masonite International, Impinj And Other Big Stocks Moving Higher On Fridaysps-com
U.S. stocks traded mixed, with the Nasdaq Composite gaining around 100 points on Friday. Shares of SPS Commerce, Inc. (NASDAQ: SPSC) rose sharply during Friday’s session following upbeat results.
Via Benzinga · February 9, 2024
12 Health Care Stocks Moving In Monday's After-Market Sessionbenzinga.com
Via Benzinga · November 27, 2023
12 Health Care Stocks Moving In Thursday's After-Market Sessionbenzinga.com
Via Benzinga · July 13, 2023
Why Lucid Group Shares Are Trading Lower By 11%? Here Are Other Stocks Moving In Wednesday's Mid-Day Sessionbenzinga.com
Gainers Healthcare Triangle, Inc. (NASDAQ: HCTI) shares climbed 171.2% to $8.84 as the company launched initiative to prevent ransomware attacks in the $35 billion healthcare data market.
Via Benzinga · July 12, 2023
IBM, ServiceNow, Lennox, Morningstar And Other Big Stocks Moving Higher On Thursdaybenzinga.com
U.S. stocks traded lower, with the Nasdaq Composite falling more than 90 points on Thursday. Here are some big stocks bucking the trend and recording gains in today’s session.
Via Benzinga · October 26, 2023
InMode, Daktronics, Domino's Pizza And Other Big Stocks Moving Higher On Wednesdaybenzinga.com
U.S. stocks traded higher, with the Dow Jones gaining around 250 points on Wednesday. Here are some big stocks recording gains in today’s session.
Via Benzinga · July 12, 2023
Pancreatic Cancer Trials & New Treatments Receiving Increased Funding as Incidences of Cancer Grows
Pancreatic Cancer Trials & New Treatments Receiving Increased Funding as Incidences of Cancer Grows
Via News Direct · June 23, 2023
Benzinga's Top Ratings Upgrades, Downgrades For June 21, 2023benzinga.com
Via Benzinga · June 21, 2023
Benzinga's Top Ratings Upgrades, Downgrades For June 12, 2023benzinga.com
Via Benzinga · June 12, 2023
Best Buy, Abercrombie & Fitch, Burlington Stores And Some Other Big Stocks Moving Higher On Tuesdaybenzinga.com
U.S. stocks traded higher, with the Dow Jones gaining around 250 points on Tuesday. Here are some big stocks recording gains in today’s session.
Via Benzinga · November 22, 2022
Benzinga's Top Ratings Upgrades, Downgrades For March 17, 2023benzinga.com
Via Benzinga · March 17, 2023